Unpublished pharma data states it has Hep C treatment cure rate of 99 percent

Dr. Barry Dworkin

Madely Health Headlines Commentary for October 16, 2012

[display_podcast]

Source:

Abbott Labs rises on hepatitis C drug data

Reference:

This press release does not cite published studies. Nor do we know if there were negative outcomes in other clinical trials. There is no obligation on the part of pharma to release details of stiudies that cast a negative outcome for their product.

 

Related posts:

  1. Animal study shows promise in Hepatitis C vaccine research
  2. Science succeeding in turning HIV into a chronic disease: People living normal and long lives
  3. C. difficile infections do occur in children and can be exacerbated by certain antibiotics
  4. FDA approves new pill developed to reduce the risk of re-infections by repopulating microbiome after patients complete antibiotic treatment for C. difficile